Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
721
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
16 Nov 2017 22:57
KOSDAQ's Bullish Run - Main Drivers & Stocks to Pick
KOSDAQ is getting really hot. Over the past three months, KOSDAQ index climbed 22.89% by 145.31 points from 642.11 on Aug 17 to 780.22 today on Nov...
Sanghyun Park
Follow
799 Views
Share
bullish
•
Korea Stock Exchange KOSPI 200
•
09 Nov 2017 16:52
Korea, Kospi 200: Targeting 400+
The MSCI Asia Free ex-Japan (MXASJ – 703) regional benchmark, is expected to exceed 1,080 before the bull market that started in 2016 ends, that’s...
Chris Roberts
284 Views
Share
bullish
•
Thematic (Sector/Industry)
•
05 Oct 2017 22:59
Foreign Investors Vs. Local Institutions in Korean Stock Market - Who Is Right?
Last month, foreign investors went on a buying spree in the Korea's second largest stock market, KOSDAQ. In contrast, they went on a selling spree...
Sanghyun Park
Follow
1.3k Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Sep 2017 09:29
The Week That Was in NorthAsia@Smartkarma: Sep24
It has been another week in North Asia. North Korean missile/nuclear tests and threats? Check. Trump rhetoric on North Korea and football players?...
Travis Lundy
Follow
397 Views
Share
bullish
•
Thematic (Sector/Industry)
•
15 Jun 2017 08:46
Sector Capsule: Colour Cosmetics in South Korea
Headlines In 2016, colour cosmetics records value sales growth of 6% to reach KRW2.3 trillion Domestic manufacturers continue to have a large...
Euromonitor International Ltd.
462 Views
Share
First
Previous
24
25
26
27
28
29
30
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x